We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ATH.AU

Price
0.01
Stock movement up
+- (%)
Company name
Alterity Therapeutics Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
41.97M
Ent value
34.75M
Price/Sales
10.44
Price/Book
3.04
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-23.15%
1 year return
60.00%
3 year return
-23.69%
5 year return
-10.59%
10 year return
-27.70%
Last updated: 2025-04-05

DIVIDENDS

ATH.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales10.44
Price to Book3.04
EV to Sales8.65

FINANCIALS

Per share

Per share data
Current share count5.25B
EPS (TTM)-0.00
FCF per share (TTM)-0.00

Income statement

Income statement data
Revenue (TTM)4.02M
Gross profit (TTM)3.87M
Operating income (TTM)-23.62M
Net income (TTM)-19.12M
EPS (TTM)-0.00
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)96.33%
Operating margin (TTM)-587.69%
Profit margin (TTM)-475.79%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash12.64M
Net receivables4.04M
Total current assets19.04M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment619.08K
Total assets19.22M
Accounts payable581.14K
Short/Current long term debt159.04K
Total current liabilities5.37M
Total liabilities5.43M
Shareholder's equity13.80M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-12.42M
Capital expenditures (TTM)6.28K
Free cash flow (TTM)-12.43M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-138.60%
Return on Assets-99.48%
Return on Invested Capital-137.53%
Cash Return on Invested Capital-89.40%

STOCK INFORMATION

Stock chart

Stock price data
Open0.01
Daily high0.01
Daily low0.01
Daily Volume6.87M
All-time high2.50
1y analyst estimate0.04
Beta0.68
EPS (TTM)-0.00
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
ATH.AUS&P500
Current price drop from All-time high-99.68%-17.56%
Highest price drop-99.88%-56.47%
Date of highest drop27 Nov 20249 Mar 2009
Avg drop from high-84.24%-11.07%
Avg time to new high268 days12 days
Max time to new high5413 days1805 days
COMPANY DETAILS
ATH.AU (Alterity Therapeutics Ltd) company logo
Marketcap
41.97M
Marketcap category
Small-cap
Description
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.
Employees
10
Website
https://alteritytherapeutics.com
Investor relations
-
SEC filings
ATH.AU SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved